Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 3, 2011, Pages 492-499

  Gonçalves, António Pedro ^a,b   Máximo, Valdemar ^b,c   Lima, Jorge ^b   Singh, Keshav K ^d   Soares, Paula ^b,c   Videira, Arnaldo ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c University of Porto   (Portugal)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Cell death; Mitotic catastrophe; P53; Rotenone

Indexed keywords

PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; ROTENONE; STAUROSPORINE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE ARREST; CELL DEATH; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GROWTH INHIBITION; MITOSIS; MITOSIS INHIBITION; PHOSPHORYLATION; PRIORITY JOURNAL; WILD TYPE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL AGING; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SYNERGISM; ENZYME INHIBITORS; FABACEAE; HUMANS; MITOCHONDRIA; MITOSIS; REACTIVE OXYGEN SPECIES; ROTENONE; STAUROSPORINE; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UNCOUPLING AGENTS;

EID: 79951906204     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.01.006     Document Type: Article

References (43)

1. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., El-Deiry W.S., Golstein P., Green D.R., Hengartner M., Knight R.A., Kumar S., Lipton S.A., Malorni W., Nunez G., Peter M.E., Tschopp J., Yuan J., Piacentini M., Zhivotovsky B., Melino G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ. 2009, 16:3-11.
2. Hotchkiss R.S., Strasser A., McDunn J.E., Swanson P.E. Cell death. N. Engl. J. Med. 2009, 361:1570-1583.
3. Vakifahmetoglu H., Olsson M., Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ. 2008, 15:1153-1162.
4. Castedo M., Perfettini J.L., Roumier T., Andreau K., Medema R., Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004, 23:2825-2837.
5. Armstrong J.S., Hornung B., Lecane P., Jones D.P., Knox S.J. Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW. Biochem. Biophys. Res. Commun. 2001, 289:973-978.
6. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 2003, 278:8516-8525.
7. Lee J., Huang M.S., Yang I.C., Lai T.C., Wang J.L., Pang V.F., Hsiao M., Kuo M.Y. Essential roles of caspases and their upstream regulators in rotenone-induced apoptosis. Biochem. Biophys. Res. Commun. 2008, 371:33-38.
8. Choi W.S., Kruse S.E., Palmiter R.D., Xia Z. Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc. Natl Acad. Sci. USA 2008, 105:15136-15141.
9. Castro A., Lemos C., Falcao A., Fernandes A.S., Glass N.L., Videira A. Rotenone enhances the antifungal properties of staurosporine. Eukaryot. Cell 2010, 9:906-914.
10. Meisner H.M., Sorensen L. Metaphase arrest of Chinese hamster cells with rotenone. Exp. Cell Res. 1966, 42:291-295.
11. Brinkley B.R., Barham S.S., Barranco S.C., Fuller G.M. Rotenone inhibition of spindle microtubule assembly in mammalian cells. Exp. Cell Res. 1974, 85:41-46.
12. Ren Y., Liu W., Jiang H., Jiang Q., Feng J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J. Biol. Chem. 2005, 280:34105-34112.
13. Srivastava P., Panda D. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J. 2007, 274:4788-4801.
14. Cunningham M.L., Soliman M.S., Badr M.Z., Matthews H.B. Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. Cancer Lett. 1995, 95:93-97.
15. Gerhauser C., Mar W., Lee S.K., Suh N., Luo Y., Kosmeder J., Luyengi L., Fong H.H., Kinghorn A.D., Moriarty R.M., et al. Rotenoids mediate potent cancer chemopreventive activity through transcriptional regulation of ornithine decarboxylase. Nat. Med. 1995, 1:260-266.
16. Yoshitani S.I., Tanaka T., Kohno H., Takashima S. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone. Int. J. Oncol. 2001, 19:929-939.
17. Tanaka T., Kohno H., Sakata K., Yamada Y., Hirose Y., Sugie S., Mori H. Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis 2002, 23:1361-1367.
18. Saffran H.A., Pare J.M., Corcoran J.A., Weller S.K., Smiley J.R. Herpes simplex virus eliminates host mitochondrial DNA. EMBO Rep. 2007, 8:188-193.
19. Kulawiec M., Owens K.M., Singh K.K. mtDNA G10398A variant in African-American women with breast cancer provides resistance to apoptosis and promotes metastasis in mice. J. Hum. Genet. 2009, 54:647-654.
20. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 1995, 92:9363-9367.
21. Chou T.C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 2006, 58:621-681.
22. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
23. Dumaz N., Meek D.W. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J. 1999, 18:7002-7010.
24. Jimenez G.S., Bryntesson F., Torres-Arzayus M.I., Priestley A., Beeche M., Saito S., Sakaguchi K., Appella E., Jeggo P.A., Taccioli G.E., Wahl G.M., Hubank M. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 1999, 400:81-83.
25. Lanni J.S., Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 1998, 18:1055-1064.
26. Andreassen P.R., Lohez O.D., Lacroix F.B., Margolis R.L. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 2001, 12:1315-1328.
27. Meireles A.M., Preto A., Rocha A.S., Rebocho A.P., Maximo V., Pereira-Castro I., Moreira S., Feijao T., Botelho T., Marques R., Trovisco V., Cirnes L., Alves C., Velho S., Soares P., Sobrinho-Simoes M. Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines. Thyroid 2007, 17:707-715.
28. Petitjean A., Mathe E., Kato S., Ishioka C., Tavtigian S.V., Hainaut P., Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 2007, 28:622-629.
29. Ottaviano L., Schaefer K.L., Gajewski M., Huckenbeck W., Baldus S., Rogel U., Mackintosh C., de Alava E., Myklebost O., Kresse S.H., Meza-Zepeda L.A., Serra M., Cleton-Jansen A.M., Hogendoorn P.C., Buerger H., Aigner T., Gabbert H.E., Poremba C. Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort. Genes Chromosom. Cancer 2010, 49:40-51.
30. Reed J.C., Jurgensmeier J.M., Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1998, 1366:127-137.
31. Schultz R.A., Swoap S.J., McDaniel L.D., Zhang B., Koon E.C., Garry D.J., Li K., Williams R.S. Differential expression of mitochondrial DNA replication factors in mammalian tissues. J. Biol. Chem. 1998, 273:3447-3451.
32. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
33. Chen Y., McMillan-Ward E., Kong J., Israels S.J., Gibson S.B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci. 2007, 120:4155-4166.
34. Kulawiec M., Ayyasamy V., Singh K.K. p53 regulates mtDNA copy number and mitocheckpoint pathway. J. Carcinog. 2009, 8:8.
35. Lebedeva M.A., Eaton J.S., Shadel G.S. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim. Biophys. Acta 2009, 1787:328-334.
36. Matsumoto K., Ohta T. Rotenone induces aneuploidy, polyploidy and endoreduplication in cultured Chinese hamster cells. Mutat. Res. 1991, 263:173-177.
37. Lee H.O., Davidson J.M., Duronio R.J. Endoreplication: polyploidy with purpose. Genes Dev. 2009, 23:2461-2477.
38. Gascoigne K.E., Taylor S.S. How do anti-mitotic drugs kill cancer cells?. J. Cell Sci. 2009, 122:2579-2585.
39. Tritarelli A., Oricchio E., Ciciarello M., Mangiacasale R., Palena A., Lavia P., Soddu S., Cundari E. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol. Biol. Cell 2004, 15:3751-3757.
40. Kato S., Han S.Y., Liu W., Otsuka K., Shibata H., Kanamaru R., Ishioka C. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl Acad. Sci. USA 2003, 100:8424-8429.
41. Eom Y.W., Kim M.A., Park S.S., Goo M.J., Kwon H.J., Sohn S., Kim W.H., Yoon G., Choi K.S. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 2005, 24:4765-4777.
42. Huang X., Tran T., Zhang L., Hatcher R., Zhang P. DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint. Proc. Natl Acad. Sci. USA 2005, 102:1065-1070.
43. Li S., Szymborski A., Miron M.J., Marcellus R., Binda O., Lavoie J.N., Branton P.E. The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells. Oncogene 2009, 28:390-400.